OTC · BICX
Healthcare · Medical - Care Facilities
$0.23
Down-$0.02 (-9.80%)
Updated Sep 20, 2026, 3:16 AM
SID Score
3.3/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
BICX does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning BICX.
BICX research
Company profile and research snapshot.
BIOCORRX INC NEW
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Sep 10, 2026
Former Acting Director of the White House Office of National Drug Control Policy Brings 28 Years of Federal Drug Policy and Addiction Expertise to BioCorRx ANAHEIM, CA - September 10, 2026 (NEWMEDIAWIRE) - BioCorRx Inc. (OTC: BICX) (the "Company"), a...
Yahoo · Aug 25, 2026
Updated NDC Records Advance BioCorRx's Commercial Transition Across all Four Product Configurations While Supporting Continuity of Product Availability ANAHEIM, CA - August 25, 2026 (NEWMEDIAWIRE) - BioCorRx Inc (OTC: BICX) (the "Company"), a develop...
defenseworld.net · Nov 30, 2025
Biocorrx (OTCMKTS:BICX - Get Free Report) and CVS Health (NYSE: CVS - Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, risk, valuation and profitability. Profitability This table compares Biocorrx and CVS Health's net
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning BICX.
No results
No recent SID articles mention BICX.
